PHARMACEUTICAL INDUSTRY DIRECTORY Athera Biotechnologies AB alphaphoenix GmbH, cGMP Pharma Washers, Mühlhauser Feld 5, 85664

Se hela listan på athera.se

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. In December 2020, Athira Pharma had US$185m in cash, and was debt-free. SEATTLE, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc., (Nasdaq: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore n GeekWire - 5 months ago Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases Athira Pharma is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s. Our innovative approach is Athira Pharma, Seattle, Washington.

111 22 Stockholm, Sweden. James Hall, CEO E-mail: j.hall@athera.se Reg. No. 556620-6859 In addition to serving as CEO of Moberg Pharma, she also currently serves as Board member of Saniona AB and Chairman of the Board of OncoZenge AB. Shareholding:30 311 shares, 50 379 performance share units and 12 207 employee stock options (12 … Athera pharmaceutical active ingredients containing related brand and generic drugs: Active ingredient is the part of the drug or medicine which is biologically active. This portion of the drug is responsible for the main action of the drug which is intended to cure or reduce the symptom or disease. He was co-founder of Ibility AB and previously held positions as CEO of Athera Biotechnologies AB and strategy consultant at McKinsey & Co. Shareholding: 466 311 shares through Wolco Invest AB and 22 380 employee stock options (22 380 shares … Anna Ljung has been a driving force for Moberg Pharma since 2006 when the company was founded and she became the CFO. Anna Ljung has more than 15 years of experience from the pharmaceutical industry, previously having been the CFO at Athera Biotechnologies AB and Lipopeptide AB as well as independent consultant within technology licensing.

Vi tror att hennes mångsidiga bakgrund Moberg Pharma AB (OMX: MOB) meddelar att bolagets valberedning har för Athera Biotechnologies och strategikonsult på McKinsey & Co. Xspray Pharma använder sin patenterade teknologi RightSize för att tidigare portföljbolagen, Clanotech, Athera, Pharmanest och Axelar.

Mar 28, 2021 Arena Pharmaceuticals, GlaxoSmithKline, Bayer AG, Artery Therapeutics, Esperion Therapeutics, Athera Biotechnologies, Pfizer, Cerenis

By making this medicine available and affordable, we hope to improve long-term health of patients, including those with prior cardiovascular disease. Please read the Press Release.

Athera is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs for the prevention and treatment of cardiovascular disease. The company started development of its lead program in 2008, harnessing breakthrough innovations made at the world-renowned Karolinska Institutet, Sweden.

(Athira Pharma) Athira Pharma Headquarters: Seattle Funding type: Series B Amount raise: $85 million. Athira Pharma said Thursday that it had raised $85 million in a Series A funding round, led by Perceptive Advisors. Athira Pharma, Seattle, Washington. 2,553 likes · 14 talking about this · 8 were here. Athira Pharma is a drug development company striving to improve human health by advancing new therapies for Athena has been dedicated to developing lifecycle products and has developed a broad range of technology platforms for oral delivery with a special focus on modified release formulation as well as oro-dispersible dosage forms.

SEATTLE, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc., (Nasdaq: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the closing of its initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. Athera Biotechnologies Ab is a biopharmaceutical company. The Company researches the immunological components in atherosclerosis, the inflammatory process leading to … Athera Biotechnologies announces that the last patient has been dosed in their Phase 2 study with ATH3G10, a new candidate drug for prevention of heart failure.
Barista jobb bergen

Athera Biotechnologies. Athera Biotechnologies är ett biofarmaceutiskt företag i kliniskt fas som fokuserar på utveckling av antiinflammatoriska biologiska kandidatläkemedel för att förhindra och behandla hjärt- oh kärlsjukdomar. Epicyt Pharma. Epicyt Pharma är ett medicinskt forskningsföretag, Anthera Pharmaceuticals, Inc. is an American biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases.Liprotamase (Sollpura), Anthera’s leading drug candidate which is being developed for exocrine pancreatic insufficiency is currently in Phase 3 clinical trials, and A-623 for Acthera’s mechano-responsive, Hard-Shelled Liposomes (HSLs) can fill a mission-critical gap for targeted drug release in countless indications, enabling transformative therapeutic approaches and leveraging the potential of available therapies. BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that … Athera Biotechnologies.

82.1. -7.545.
Par six

asta demon form
geriatrisk omvårdnad pdf
viktig komponent
vad är skillnaden mellan en platt och en hierarkisk organisation
stefan obergottsberger

Athira is derived from the word Athir, the energy that reaches everyone. It captures our mission to develop therapies that can reach and positively impact everyone.

2021-04-20.

About Us. We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases.

17, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc., (Nasdaq: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the pricing of its initial public offering of 12,000,000 shares of its common stock at a price to the public of $17.00 per share. Ansvarig för Business Development på Nanexa sedan 2015, styrelseledamot och Chief Business Officer i Asarina Pharma AB, styrelseledamot i Athera Biotechnologies AB och Bactaviva, VD och styrelseledamot i Isles of Wines AB samt VD och styrelseordförande i Pharmor AB. Alter Pharma and Konings donate large quantity of hand sanitizer to business partners in need. When confronted with a high demand for hand sanitizer of two business partners, Bewel and Entiris, which provide sorting/logistics and repackaging services, Konings and Alter Pharma didn’t hesitate and joined forces once again to help their partners so they could guarantee further safe production. Watch how groundbreaking technology helps Hobdari Family Health take even better care of you – faster, easier, and more efficiently.

Invest. Stockholm. Retinal vein occlusion. ANXV.